Response to Saiz et al., "Misreporting of a Plasma Rich in Growth Factors Trial on Knee Osteoarthritis".

导出 LinkOut

翻译打印收藏纠错

第一作者： Mikel,Sánchez

第一单位： Advanced Biological Therapy Unit, Hospital Vithas San Jose, Vitoria-Gasteiz, Spain; Arthroscopic Surgery Unit, Hospital Vithas San Jose, Vitoria-Gasteiz, Spain.

作者： Mikel,Sánchez ^[1] ; Nicolas,Fiz ^[1] ; Juan,Azofra ^[1] ; Jaime,Usabiaga ^[2] ; Enmanuel Aduriz,Recalde ^[2] ; Antonio,García Gutierrez ^[2] ; Javier,Albillos ^[3] ; Ramón,Garate ^[3] ; Jose Javier,Aguirre ^[4] ; Sabino,Padilla ^[5] ; Gorka,Orive ^[5] ; Eduardo,Anitua ^[5]

作者单位： Advanced Biological Therapy Unit, Hospital Vithas San Jose, Vitoria-Gasteiz, Spain; Arthroscopic Surgery Unit, Hospital Vithas San Jose, Vitoria-Gasteiz, Spain. ^[1] Hospital Donostia, Donostia-San Sebastián, Spain. ^[2] Policlínica Gipuzkoa, Donostia-San Sebastián, Spain. ^[3] Department of Pathological Anatomy, OSI Hospital Universitario de Álava, Vitoria, Spain. ^[4] University Institute for Regenerative Medicine and Oral Implantology (UPV/EHUFundación Eduardo Anitua), Vitoria, Spain; BTI Biotechnology Institute, Vitoria, Spain. ^[5]

主题词人类(Humans);透明质酸(Hyaluronic Acid);注射, 关节内(Injections, Intra-Articular);胞间信号肽类和蛋白质类(Intercellular Signaling Peptides and Proteins);骨关节炎, 膝(Osteoarthritis, Knee);富血小板血浆(Platelet-Rich Plasma)

DOI 10.1016/j.arthro.2020.01.003

PMID 32139043

发布时间 2020-04-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交